Citations

Clear

1011 citation(s) found for "Barry, WT".

Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions
Peters, Anthony E. , Borlaug, Barry A. , Sweitzer, Nancy K. , Kitzman, Dalane W. , Mentz, Robert J. , Borlaug, Barry A , Mentz, Robert J , Tromp, Jasper , Shah, Sanjiv J , Lam, Carolyn S.P. , Lewis, Gregory D. , Sharma, Kavita , Pandey, Ambarish

Mayo Clinic

Cardiovascular Research | November 29, 2022 | Volume: 118 | Issue: 18 | Pages: 3403-3415

10.1093/cvr/cvac179 | PMID 36448685 Get It

Abstract Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity with complex pathophysiology and manifestations. Phenomapping is the process of applying statistical learning techniques to patient data to identify distinct subgroups based on patterns in the data. Phenomapping has emerged as a technique with potential to improve the understanding of different HFpEF phenotypes. Phenomapping efforts have been increasing in HFpEF over the past several years using a variety of data sources, clinical variables, and statistical techniques. This review summarizes methodologies and key takeaways from these studies, including consistent discriminating factors and conserved HFpEF phenotypes. We argue that phenomapping results to date have had limited implications for clinical care and clinical trials, given that the phenotypes, as currently described, are not reliably identified in each study population and may have significant overlap. We review the inherent limitations of aggregating and utilizing phenomapping results. Lastly, we discuss potential future directions, including using phenomapping to optimize the likelihood of clinical trial success or to drive discovery in mechanisms of the disease process of HFpEF.
Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea
Omote, Kazunori , Sorimachi, Hidemi, Popović, Dejana , Reddy, Yogesh N.V. , Nishimura, Rick , Verbrugge, Frederik H. , Omar, Massar , Obokata, Masaru , Borlaug, Barry A.

Mayo Clinic

European Journal of Heart Failure | November 24, 2022 | Volume: 25 | Issue: 2 | Pages: 185-196

10.1002/ejhf.2747 | PMID 36420788 Get It

Abstract Aims Little data are available regarding prognostic implications of invasive exercise testing in heart failure with preserved ejection fraction (HFpEF). The present study aimed to investigate whether rest and exercise central haemodynamic abnormalities are associated with adverse clinical outcomes in patients with dyspnea. Methods and results Patients with exertional dyspnoea and ejection fraction ≥50% (n = 764) underwent invasive exercise testing and follow-up for heart failure hospitalization or death. There were 117 patients with events over a median follow-up of 2.7 (interquartile range 0.5–4.6) years. Among patients with normal resting pulmonary artery wedge pressure (PAWP) (<15 mmHg, n = 380 [50%]), increased exercise PAWP (≥25 mmHg) was present in 187 (24% of cohort) and was associated with 2.4-fold higher risk of events compared to those with normal exercise PAWP (<25 mmHg, n = 193 [25%]) (hazard ratio [HR] 2.44; 95% confidence interval [CI] 1.11–5.36; p = 0.03), while patients with elevated resting PAWP (≥15 mmHg, n = 384 [50%]) displayed even higher risk compared to HFpEF with normal resting PAWP (HR 2.24; 95% CI 1.38–3.65; p = 0.001). Similar findings were observed for rest/exercise right atrial pressure, and rest/exercise pulmonary artery pressures. Higher peak oxygen consumption was associated with decreased risk of events, and this relationship was solely explained by exercise cardiac output. In a multivariable-adjusted Cox model, each 1 standard deviation (SD) increase in exercise PAWP was associated with a 41% greater hazard of events (HR 1.41; 95% CI 1.13–1.76; p = 0.002), while each 1 SD decrease in exercise cardiac output was associated with a 37% increased risk (HR 0.63; 95% CI 0.47–0.83; p = 0.001). Conclusions Haemodynamic abnormalities currently used for diagnosis of HFpEF are associated with increased risk for adverse events. Treatments that reduce central pressures while improving cardiac output reserve may offer greatest benefit to improve outcomes in HFpEF.
Network Model Compensation For Single-Point Measurements Of Multi-Pin Devices When Using Non-Invasive Current Estimation
Smutzer, Chad M., Keuseman, Jordan R., Haider, Clifton R. , Gilbert, Barry K.

Mayo Clinic

2022 IEEE 31st Conference on Electrical Performance of Electronic Packaging and Systems (EPEPS) | November 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: 1-3

10.1109/epeps53828.2022.9947165 Get It

Pulmonary vascular reserve with exercise in heart failure
Omote, Kazunori , Borlaug, Barry A. , Borlaug, Barry A

Mayo Clinic

European Heart Journal | November 7, 2022 | Volume: 43 | Issue: 42 | Pages: 4516-4517

10.1093/eurheartj/ehac540 | PMID 36335982 Get It

Response by Borlaug and Shah Regarding Article, “Latent Pulmonary Vascular Disease and Therapeutic Atrial Shunt”
Borlaug, Barry A. , Shah, Sanjiv J. , Borlaug, Barry A , Shah, Sanjiv J

Mayo Clinic

Circulation | October 31, 2022 | Volume: 146 | Issue: 18 | Pages: No page available

10.1161/circulationaha.122.061977 | PMID 36315605 Get It

Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses
Lu, Shao‐Chia , Barry, Michael A. , Barry, Michael A

Mayo Clinic

Expert Opinion on Biological Therapy | October 27, 2022 | Volume: 22 | Issue: 11 | Pages: 1359-1378

10.1080/14712598.2022.2139601 | PMID 36300528 Get It

Changes in adipose tissue depots and cardiac geometry following bariatric surgery
Henry, John A. , Abdesselam, Inès, Sorimachi, Hidemi, Rayner, J J, Deal, Oscar , Rider, O J, Byrne, James Patrick , Neubauer, Stefan , Borlaug, Barry A.

Mayo Clinic

European Heart Journal | October 15, 2022 | Volume: 43 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehac544.2388 Get It

Abstract Introduction Cardiac geometry is affected by body composition, with total body adipose volume being related to left ventricular (LV) dilatation (due to increased intravascular volume and cardiac output), and visceral adipose tissue (VAT) to smaller LV cavity size and concentric remodelling (because of insulin resistance) [1]. As such we hypothesised that changes in VAT and total body weight during weight loss would have a differential impact on cardiac geometry. Alongside this, we hypothesised that, as the pericardium is a fixed volume, changes in epicardial adipose tissue (EAT), may have an additional mechanical effect by reducing pericardial restraint. Purpose We sought to investigate long term changes in VAT, total weight and EAT following bariatric surgery and relate them to changes in cardiac geometry. Methods Forty patients underwent cardiac magnetic resonance (CMR) imaging before and after bariatric surgery, including 21 who underwent short-term (median 209 days), 28 medium-term (median 428 days) and 12 long-term (median 1030 days) imaging follow up. Cardiac volumes (left atrial (LA), LV end-diastolic volume (LVEDV) and stroke volume (LVSV)) were assessed using cardiac MRI. VAT was assessed at L5 using a T1 weighted, water suppressed sequence. EAT volumes were calculated by manual contouring in end-ventricular systole on short axis slices from the mitral valve to the apex. Percentage changes in volumes were calculated between scans for each individual. Results Patients on average lost 32kg within the first 428 days following bariatric surgery (54% excess weight loss, p<0.0001), with no significant change in weight at the longer-term time point (Figure 1A). Most VAT loss occurred in the first 209 days (−42%, p<0.0001) with no subsequent change observed at the final two timepoints (Figure 1B). Similarly, EAT loss occurred in the first 209 days (−13%, mean 10ml, p<0.0001) with non-significant changes thereafter (Figure 1C). There was a significant decrease in both LA (13%, mean 12ml, p<0.0001) and LVEDV (4%, mean 8ml, p=0.0249) at 209 days post-surgery. Both LA volume and LVEDV had returned to baseline by the longest term time point of 1030 days (Figure 2). LVSV followed a similar pattern being reduced at 209 days (by 10%, mean 9ml, p=0.0019), then returning to levels similar to those pre-weight loss at 1030 days (p=0.44) (Figure 2C). Conclusions Cardiac volumes show a biphasic response to weight loss, initially becoming smaller and then returning to baseline by 1030 days. We hypothesise that the early drop in LA and LV cavity size is a response to reduced volume from body mass reduction. In contrast, we propose that the increase in LA and LVEDV that follows results from the longer-term effects of reducing VAT, and increased space within the pericardium resulting from EAT loss allowing expansion to occur. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): We acknowledge support from the British Heart Foundation Oxford Center of Research Excellence
Prognostic Implications of Exercise-Induced Hypertension in Adults With Repaired Coarctation of Aorta
Egbe, Alexander C. , Miranda, William R. , Jain, C. Charles , Borlaug, Barry A. , Connolly, Heidi M. , Borlaug, Barry A

Mayo Clinic

Hypertension | October 13, 2022 | Volume: 79 | Issue: 12 | Pages: 2796-2805

10.1161/hypertensionaha.122.19735 | PMID 36252107 Get It

Background: The purpose of this study was to assess the relationship between exercise-induced hypertension (EIH) and cardiovascular events, and to determine whether exercise blood pressure (BP) improved risk stratification in adults with repaired coarctation of aorta. Methods: Retrospective study of patients with repaired coarctation of aorta on antihypertensive therapy that underwent exercise testing and exercise test (2003–2019). BP was measured at rest in 3 different clinical settings and averaged to determine the resting BP. Indices of left ventricular function and afterload were obtained from the echocardiogram. EIH was defined as systolic BP >210 (males) or >190 (females) at peak exercise. Cardiovascular event was defined as atrial fibrillation, ventricular tachycardia, heart failure hospitalization, heart transplant, and cardiovascular death. Results: Of 327 patients (age 35±13 years), 116 (35%) had EIH. Although the resting BP was similar between patients with versus without EIH, the EIH group had higher pulsatile arterial load, more advanced left ventricular remodeling, and were less likely to be on angiotensin converting enzyme inhibitor/angiotensin receptor blocker. EIH was associated with cardiovascular events (hazard ratio, 1.06 [95% CI, 1.02–1.08]) independent of resting systolic BP, and improved prognostic accuracy above resting systolic BP ( C statistic, 0.671 [95% CI, 0.645–0.694] to 0.727 [95% CI, 0.709–0.750]; P =0.01). Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker was associated with a lower risk of cardiovascular events. Conclusions: EIH was associated with cardiovascular events independent of resting BP, and patients receiving angiotensin-converting enzyme inhibitor/angiotensin receptor blocker had lower risk of cardiovascular events. These data suggest that exercise BP could be used to assess adequacy of antihypertensive therapy, and to guide titration of antihypertensive therapy.
Inspiratory and leg muscle blood flows during inspiratory muscle metaboreflex activation in heart failure with preserved ejection fraction
Hammer, Shane M. , Bruhn, Eric J., Bissen, Thomas G. , Muer, Jessica, Villarraga, Nicolas , Olson, Thomas P. , Smith, Joshua R. , Muer, Jessica D, Smith, Joshua R , Borlaug, Barry A.

Mayo Clinic

Journal of Applied Physiology | October 13, 2022 | Volume: 133 | Issue: 5 | Pages: 1202-1211

10.1152/japplphysiol.00141.2022 | PMID 36227167 Get It

Respiratory muscle dysfunction is thought to contribute to exercise intolerance in heart failure with preserved ejection fraction (HFpEF); however, the underlying mechanisms are unknown. In the present study, patients with HFpEF had greater increases in leg muscle vascular resistance index and greater decreases in leg muscle blood flow index compared with controls during inspiratory resistive breathing (to activate the metaboreflex). Furthermore, respiratory muscle blood flow index responses normalized to pressure generation during inspiratory resistive breathing were exaggerated in HFpEF compared with controls.
Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
Imperiale, Thomas F. , Lavin, Philip T. , Marti, Tara N. , Jakubowski, Debbie , Itzkowitz, Steven H. , May, Folasade P. , Limburg, Paul J. , Sweetser, Seth , Daghestani, Anas , Berger, Barry M. , Limburg, Paul J

Mayo Clinic

Cancer Prevention Research | October 7, 2022 | Volume: 16 | Issue: 2 | Pages: 89-97

10.1158/1940-6207.capr-22-0238 | PMID 36205504 Get It

Abstract Data supporting the clinical utility of multi-target stool DNA (mt-sDNA) at the guideline-recommended 3-year interval have not been reported. Between April 2015 and July 2016, candidates for colorectal cancer screening whose providers prescribed the mt-sDNA test were enrolled. Participants with a positive baseline test were recommended for colonoscopy and completed the study. Those with a negative baseline test were followed annually for 3 years. In year 3, the mt-sDNA test was repeated and colonoscopy was recommended independent of results. Data were analyzed using the Predictive Summary Index (PSI), a measure of the gain in certainty for dichotomous diagnostic tests (where a positive value indicates a net gain), and by comparing observed versus expected colorectal cancers and advanced precancerous lesions. Of 2,404 enrolled subjects, 2,044 (85%) had a valid baseline mt-sDNA result [284 (13.9%) positive and 1,760 (86.1%) negative]. Following participant attrition, the year 3 intention to screen cohort included 591 of 1,760 (33.6%) subjects with valid mt-sDNA and colonoscopy results, with no colorectal cancers and 63 advanced precancerous lesions [22 (34.9%) detected by mt-sDNA] and respective PSI values of 0% (P = 1) and 9.3% (P = 0.01). The observed 3-year colorectal cancer yield was lower than expected (one-sided P = 0.09), while that for advanced precancerous lesions was higher than expected (two-sided P = 0.009). Repeat mt-sDNA screening at a 3-year interval resulted in a statistically significant gain in detection of advanced precancerous lesions. Due to absence of year 3 colorectal cancers, the PSI estimate for colorectal cancer was underpowered and could not be reliably quantified. Larger studies are required to assess the colorectal cancer study findings. Prevention Relevance: Understanding the 3-year yield of mt-sDNA for colorectal cancer and advanced precancerous polyps is required to ensure the clinical appropriateness of the 3-year interval and to optimize mt-sDNA's screening effectiveness.